CAR T-cell therapy in refractory large B-cell lymphoma

被引：11
|
作者：
Stirrups, Robert
机构：
来源：
LANCET ONCOLOGY | 2018年 / 19卷 / 01期
关键词：
D O I：
10.1016/S1470-2045(17)30928-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E19 / E19
页数：1
相关论文
共 50 条
  • [21] Identifying the Barriers of Clinical Trial Access after CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma
    Kim, Kunhwa
    Ayers, Amy
    Ahmed, Sairah
    Claret, Linda
    Strati, Paolo
    Nair, Ranjit
    Nze, Chijioke
    Ramdial, Jeremy
    Torres, Janet
    Shpall, Elizabeth J.
    Fayad, Luis E.
    Nastoupil, Loretta
    Westin, Jason R.
    Flowers, Christopher R.
    Neelapu, Sattva S.
    Chihara, Dai
    BLOOD, 2024, 144 : 5121 - 5122
  • [22] Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma
    Vercellino, Laetitia
    Di Blasi, Roberta
    Kanoun, Salim
    Tessoulin, Benoit
    Rossi, Cedric
    D'Aveni-Piney, Maud
    Oberic, Lucie
    Bodet-Milin, Caroline
    Bories, Pierre
    Olivier, Pierre
    Lafon, Ingrid
    Berriolo-Riedinger, Alina
    Galli, Eugenio
    Bernard, Sophie
    Rubio, Marie-Therese
    Bossard, Celine
    Meignin, Veronique
    Merlet, Pascal
    Feugier, Pierre
    Le Gouill, Steven
    Ysebaert, Loic
    Casasnovas, Olivier
    Meignan, Michel
    Chevret, Sylvie
    Thieblemont, Catherine
    BLOOD ADVANCES, 2020, 4 (22) : 5607 - 5615
  • [23] CAR T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Progressive Muscular Dystrophy: A Case Report
    Chen, Liting
    Xu, Bin
    Liu, Wanying
    Wang, Di
    Xu, Jinhuan
    Mao, Xia
    Xiao, Min
    Zhou, Jianfeng
    Xiao, Yi
    ONCOTARGETS AND THERAPY, 2022, 15 : 361 - 366
  • [24] Outcomes with loncastuximab tesirine following CAR T-cell therapy in patients with relapsed or refractory diffuse large B-cell lymphoma
    Epperla, Narendranath
    Lucero, Melanie
    Bailey, Tom
    Mirams, Laura
    Cheung, Jolenta
    Amet, Mona
    Milligan, Gary
    Chen, Lei
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [25] Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma
    Liu, Wei
    Zou, Hesong
    Chen, Lianting
    Huang, Wenyang
    Lv, Rui
    Xu, Yan
    Liu, Huimin
    Shi, Yin
    Wang, Kefei
    Wang, Yi
    Xiong, Wenjie
    Deng, Shuhui
    Yi, Shuhua
    Sui, Weiwei
    Peng, Guangxin
    Ma, Yueshen
    Wang, Huijun
    Lv, Lulu
    Wang, Jianxiang
    Wei, Jun
    Qiu, Lugui
    Zheng, Wenting
    Zou, Dehui
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
  • [26] FDG PET/MR for therapy response evaluation of CAR T-cell therapy in large B-cell lymphoma
    Sjoholm, T.
    Korenyushkin, A.
    Kullberg, J.
    Enblad, G.
    Ahlstrom, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S411 - S411
  • [27] Effect of Delayed Cell Infusion in Patients with Large B-Cell Lymphoma Treated with CAR T-Cell Therapy
    Jallouk, Andrew
    Feng, Lei
    Noorani, Mansoor
    Das, Kaberi
    Steiner, Raphael E.
    Nastoupil, Loretta J.
    Hawkins, Misha
    Nair, Ranjit
    Westin, Jason
    Fayad, Luis
    Chihara, Dai
    Castillo, Luis Enrique Malpica
    Iyer, Swaminathan P.
    Ahmed, Sairah
    Shpall, Elizabeth J.
    Kebriaei, Partow
    Neelapu, Sattva S.
    Strati, Paolo
    BLOOD, 2022, 140 : 10424 - 10426
  • [28] Radiotherapy as bridging strategy in Large B-cell lymphoma patients selected for CAR T-cell therapy
    Niezink, A.
    Beijert, M.
    van Doesum, J.
    Muijs, C. T.
    Langendijk, J. A.
    Busz, D. M.
    Crijns, A. P.
    van Meerten, T.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S137 - S138
  • [29] Severe Persistent Cytopenias Following CAR T-Cell Therapy in Patients with Large B-Cell Lymphoma
    Corona De Lapuerta, Magdalena
    Shouval, Roni
    Alarcon Tomas, Ana
    Flynn, Jessica R.
    Devlin, Sean M.
    Batlevi, Connie Lee
    Fein, Joshua A.
    Giralt, Sergio A.
    Lin, Richard J.
    Nath, Karthik
    Palomba, Maria Lia
    Parascondola, Allison
    Shah, Gunjan L.
    Salles, Gilles
    Scordo, Michael
    Walji, Moneeza
    Perales, Miguel-Angel
    Dahi, Parastoo B.
    BLOOD, 2022, 140 : 12770 - 12772
  • [30] CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma
    Alejandro Luna
    Sean M. Devlin
    Kai Rejeski
    Jessica R. Flynn
    Magdalena Corona
    Efrat Luttwak
    Alfredo Rivas-Delgado
    Ivan Landego
    Giulio Cassanello
    Marina Gomez-Llobell
    Sandeep S. Raj
    Parastoo B. Dahi
    Richard J. Lin
    Allison Parascondola
    M.Lia Palomba
    Gunjan L. Shah
    Michael Scordo
    Ana Alarcon Tomas
    Doris Leithner
    Akshay Bedmutha
    Heiko Schöder
    Brandon S. Imber
    Gilles Salles
    Jae H. Park
    Miguel-Angel Perales
    Roni Shouval
    Blood Cancer Journal, 15 (1)
12345